INGN-403

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameINGN-403
Drug Alias NameIL-24/mda-7 (Introgen)INGN-403
ClassificationBiologics
Mechanisms of ActionInterleukin 24 stimulants
TargetsInterleukin 24
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntrogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntrogen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A